Angela A. Armstrong

Array ( [id] => 5682959 [patent_doc_number] => 20060199229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Methods for identification of modulators of OSGPR116 activity, and their use in the treatment of disease' [patent_app_type] => utility [patent_app_number] => 11/397181 [patent_app_country] => US [patent_app_date] => 2006-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31120 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199229.pdf [firstpage_image] =>[orig_patent_app_number] => 11397181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056366 [patent_doc_number] => 20070059288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Treatment for heart disease' [patent_app_type] => utility [patent_app_number] => 11/394537 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36047 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059288.pdf [firstpage_image] =>[orig_patent_app_number] => 11394537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538679 [patent_doc_number] => 20090220484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'Rage/Diaphanous Interaction and Related Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 11/886651 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 5432 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220484.pdf [firstpage_image] =>[orig_patent_app_number] => 11886651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434954 [patent_doc_number] => 20090169540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Use Of An Antagonist Of Epac For Treating Human Cardiac Hypertrophy' [patent_app_type] => utility [patent_app_number] => 11/885452 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18123 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169540.pdf [firstpage_image] =>[orig_patent_app_number] => 11885452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509053 [patent_doc_number] => 20090082260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'COMBINATION OF AN IMMUNOSUPPRESSANT AND A PPAR GAMMA AGONIST FOR THE TREATMENT OF AN UNDESIRABLE IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 11/816933 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14322 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082260.pdf [firstpage_image] =>[orig_patent_app_number] => 11816933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9922990 [patent_doc_number] => 08980952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-17 [patent_title] => 'Methods for treating brain swelling with a compound that blocks a non-selective cation channel' [patent_app_type] => utility [patent_app_number] => 11/359946 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 78 [patent_no_of_words] => 62118 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11359946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693702 [patent_doc_number] => 20060153849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Methods of treatment with an antibody that suppresses growth differentiation factor-14 activity' [patent_app_type] => utility [patent_app_number] => 11/353277 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7838 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153849.pdf [firstpage_image] =>[orig_patent_app_number] => 11353277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663136 [patent_doc_number] => 20080254043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Drug For Treating Ischemic Disease' [patent_app_type] => utility [patent_app_number] => 11/883646 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9338 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254043.pdf [firstpage_image] =>[orig_patent_app_number] => 11883646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5618970 [patent_doc_number] => 20060188503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'Modulation of eNOS activity and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/346596 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19708 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188503.pdf [firstpage_image] =>[orig_patent_app_number] => 11346596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515390 [patent_doc_number] => 20090215697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'COMPOSITION FOR THE TREATMENT OF ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 11/813071 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10893 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215697.pdf [firstpage_image] =>[orig_patent_app_number] => 11813071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4932423 [patent_doc_number] => 20080003198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-03 [patent_title] => 'Hernia treatment agents' [patent_app_type] => utility [patent_app_number] => 11/318927 [patent_app_country] => US [patent_app_date] => 2005-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4068 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20080003198.pdf [firstpage_image] =>[orig_patent_app_number] => 11318927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927371 [patent_doc_number] => 20080166734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Genes and methods of using the same for diagnosis and for targeting the therapy of cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 11/315754 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25526 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166734.pdf [firstpage_image] =>[orig_patent_app_number] => 11315754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279179 [patent_doc_number] => 20090131311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Method for Preventing Formation of Trisulfide Derivatives of Polypeptides' [patent_app_type] => utility [patent_app_number] => 11/813045 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4902 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131311.pdf [firstpage_image] =>[orig_patent_app_number] => 11813045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715577 [patent_doc_number] => 20060078940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => '21132, a human G-protein coupled receptor family member and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/296524 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 42219 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078940.pdf [firstpage_image] =>[orig_patent_app_number] => 11296524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843230 [patent_doc_number] => 20060121514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Prostacyclin-stimulating Factor-2' [patent_app_type] => utility [patent_app_number] => 11/294448 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 92831 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121514.pdf [firstpage_image] =>[orig_patent_app_number] => 11294448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5715584 [patent_doc_number] => 20060078947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 1521, 6662, 13913, 12405 or 5014' [patent_app_type] => utility [patent_app_number] => 11/288493 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65079 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078947.pdf [firstpage_image] =>[orig_patent_app_number] => 11288493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479515 [patent_doc_number] => 20090202472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'MOLECULES AND CHIMERIC MOLECULES THEREOF' [patent_app_type] => utility [patent_app_number] => 11/816405 [patent_app_country] => US [patent_app_date] => 2005-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 96128 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202472.pdf [firstpage_image] =>[orig_patent_app_number] => 11816405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326766 [patent_doc_number] => 07514537 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Chimeric immunoreceptor useful in treating human gliomas' [patent_app_type] => utility [patent_app_number] => 11/274344 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 17 [patent_no_of_words] => 13007 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514537.pdf [firstpage_image] =>[orig_patent_app_number] => 11274344 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720791 [patent_doc_number] => 20060073566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Active modified hedgehog proteins' [patent_app_type] => utility [patent_app_number] => 11/273989 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 7523 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073566.pdf [firstpage_image] =>[orig_patent_app_number] => 11273989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5913559 [patent_doc_number] => 20060128621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use' [patent_app_type] => utility [patent_app_number] => 11/273724 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128621.pdf [firstpage_image] =>[orig_patent_app_number] => 11273724 [rel_patent_id] =>[rel_patent_doc_number] =>)